Monoclonal antibody treatments help AdventHealth doctors keep high-risk COVID patients out…

first_imgShare on Facebook Tweet on Twitter You have entered an incorrect email address! Please enter your email address here Please enter your name here The Anatomy of Fear Free webinar for job seekers on best interview answers, hosted by Goodwill June 11 Support conservation and fish with NEW Florida specialty license plate Save my name, email, and website in this browser for the next time I comment.center_img LEAVE A REPLY Cancel reply Please enter your comment! TAGSAdventHealthAntibodiesCOVID-19Dr. Michael CacciatorehealthHospitalMonoclonalMorning BriefingYoung People Previous articleEarth Day saw environmentalists push to save bees, needed in FloridaNext articlePact granting Seminoles exclusive control of Florida sports gaming ‘imminent’ Denise Connell RELATED ARTICLESMORE FROM AUTHOR Photo by Steven Cornfield But the number of younger hospitalized patients is increasing among those who are not vaccinated.From AdventHealthMonoclonal antibodies, available at AdventHealth outpatient clinics across Central Florida, have emerged as a key treatment to prevent many high-risk patients with COVID-19 from developing severe disease that requires hospitalization, said Dr. Michael Cacciatore, chief medical officer for AdventHealth Medical Group, at today’s AdventHealth Morning Briefing.He said the hospital system is seeing at least a 50% reduction in admissions among people who receive the infusions of synthetic antibodies, which help stop the coronavirus from reproducing inside the body and causing worse symptoms.Dr. Eduardo OliveiraAt the same time, however, physicians are seeing younger unvaccinated patients admitted to the hospital, said Dr. Eduardo Oliveira, medical director of critical care services at AdventHealth Medical Group. About 430 people are hospitalized with COVID-19 across AdventHealth’s Central Florida hospitals, a slight increase from the prior week.Patients as young as 23 have been recently hospitalized because of COVID-19, said Oliveira, who treats patients in the Intensive Care Unit. Most recent hospitalizations are people who have not received the vaccine, he said, a sign that the vaccine is working among the senior population who once dominated the group of patients sick enough to be admitted to the hospital.Both doctors recommend people get the vaccine and continue good hygiene practices such as wearing masks, washing hands and social distancing.Monoclonal antibody treatments are for those who have tested positive for COVID-19 and had mild-to-moderate symptoms within the last 10 days and are at high risk for progressing to a more severe case. To qualify, patients must be referred by a physician and must also have a high-risk factor such as diabetes, heart disease or obesity.Community members with questions about monoclonal antibody treatments can call the AdventHealth Coronavirus Information Line at 877-VIRUS-HQ (877-847-8747).last_img

Leave a Reply

Your email address will not be published. Required fields are marked *